IRIS UniCatt

Martinotti, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.640
NA - Nord America 5.715
AS - Asia 3.960
SA - Sud America 724
AF - Africa 97
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 4
Totale 19.177
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.572
IT - Italia 4.151
SG - Singapore 1.834
DE - Germania 1.718
CN - Cina 942
BR - Brasile 591
SE - Svezia 546
FR - Francia 535
UA - Ucraina 421
VN - Vietnam 358
GB - Regno Unito 302
IE - Irlanda 180
NL - Olanda 173
IN - India 163
FI - Finlandia 140
ID - Indonesia 122
RU - Federazione Russa 110
JP - Giappone 107
HK - Hong Kong 82
TR - Turchia 75
CA - Canada 66
CH - Svizzera 66
PL - Polonia 53
ES - Italia 51
MX - Messico 51
AR - Argentina 46
BD - Bangladesh 44
BE - Belgio 31
AU - Australia 30
IQ - Iraq 27
ZA - Sudafrica 24
RO - Romania 23
AT - Austria 21
IR - Iran 21
SA - Arabia Saudita 20
CL - Cile 19
AL - Albania 16
VE - Venezuela 16
MA - Marocco 15
CI - Costa d'Avorio 14
CO - Colombia 14
EC - Ecuador 14
PK - Pakistan 14
CZ - Repubblica Ceca 13
HU - Ungheria 13
NP - Nepal 13
IL - Israele 12
PH - Filippine 11
JO - Giordania 10
AE - Emirati Arabi Uniti 9
KE - Kenya 9
KR - Corea 9
LT - Lituania 9
PE - Perù 9
EG - Egitto 8
GR - Grecia 8
KZ - Kazakistan 8
MT - Malta 8
PT - Portogallo 8
TH - Thailandia 8
TW - Taiwan 8
UZ - Uzbekistan 8
NZ - Nuova Zelanda 7
OM - Oman 7
RS - Serbia 7
TN - Tunisia 7
UY - Uruguay 7
AM - Armenia 6
DZ - Algeria 6
HR - Croazia 6
MY - Malesia 6
DO - Repubblica Dominicana 5
LB - Libano 5
LV - Lettonia 5
PS - Palestinian Territory 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
KG - Kirghizistan 4
LU - Lussemburgo 4
NG - Nigeria 4
PY - Paraguay 4
BO - Bolivia 3
BY - Bielorussia 3
DK - Danimarca 3
ET - Etiopia 3
MC - Monaco 3
NO - Norvegia 3
QA - Qatar 3
BG - Bulgaria 2
BH - Bahrain 2
BZ - Belize 2
CR - Costa Rica 2
EE - Estonia 2
EU - Europa 2
GT - Guatemala 2
JM - Giamaica 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
MN - Mongolia 2
Totale 19.148
Salva come PNG Salva come JPEG
Città #
Singapore 938
Chandler 767
Ashburn 638
San Jose 562
Milan 503
Rome 421
Jacksonville 210
San Mateo 189
Dublin 172
Beijing 160
Wilmington 147
New York 126
Nanjing 123
Ho Chi Minh City 119
Lauterbourg 115
Los Angeles 109
Jakarta 108
Woodbridge 97
Hanoi 94
St Louis 94
The Dalles 85
Dearborn 83
Hefei 78
Tokyo 78
Nürnberg 76
Munich 72
Frankfurt am Main 71
Boston 70
Ann Arbor 67
Redwood City 67
Turin 64
Hong Kong 60
Bologna 59
Florence 59
Moscow 59
Lawrence 56
Marseille 56
São Paulo 56
Houston 55
Seattle 54
Naples 52
Norwalk 50
Bremen 49
Nanchang 48
Burlington 45
Lancaster 42
Paris 42
Fairfield 41
Buffalo 40
Princeton 40
Catania 38
Genoa 38
Council Bluffs 36
Verona 36
Bari 35
Brescia 34
Cattolica 34
Helsinki 34
Chicago 33
Dallas 33
Guangzhou 33
Palermo 33
Falls Church 32
University Park 30
Santa Clara 29
Changsha 27
Mountain View 27
Tianjin 26
Hebei 24
Warsaw 24
Boardman 23
Izmir 23
London 23
Brussels 22
Hangzhou 22
Shanghai 22
Mexico City 21
Perugia 20
Shenyang 20
Chennai 19
Kent 19
Pune 19
Cambridge 18
Da Nang 18
Fremont 18
Haiphong 18
Toronto 18
Messina 17
Padova 17
Modena 16
Orem 16
Torino 16
Jiaxing 15
Kunming 15
Tirana 15
Abidjan 14
Stockholm 14
Atlanta 13
Denver 13
Pescara 13
Totale 8.639
Salva come PNG Salva come JPEG
Nome #
L efficacia del topiramato a basso dosaggio in pazienti alcolisti in fase di post-disintossicazione 3.046
Psychometric characteristic of the Italian version of the Temperament and Character Inventory--revised, personality, psychopathology, and attachment styles 649
Quetiapine as add-on treatment for Bipolar I Disorder with comorbid compulsive buying and physical exercise addiction 555
Comorbilità tra Disturbi da Uso di Sostanze e disturbi affettivi 455
Craving Typology Questionnaire (CTQ): a scale for alcohol craving in normal controls and alcoholics 407
Description and validation of a questionnaire for the detection of meteoropathy and meteorosensitivity: the METEO-Q 354
Bipolar disorder and gambling disorder comorbidity: current evidence and implications for pharmacological treatment 318
Behavioural addictions in bipolar disorder patients: Role of impulsivity and personality dimensions 277
Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial. 264
Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial 261
[Diagnosis of deficit and attention/hyperactivity disorders (ADHD) in patients with bipolar or unipolar depression: an experimental study] 211
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up 210
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up. 210
Further evidence supporting the association between 5HTR2C gene and bipolar disorder 199
Problematic mobile phone use in adolescence: A cross-sectional study 195
Role of Substance Abuse Comorbidity and Personality on the Outcome of Depression in Bipolar Disorder: Harm Avoidance Influences Medium-Term Treatment Outcome. 194
[Diagnosis of deficit and attention/hyperactivity disorders (ADHD) in patients with bipolar or unipolar depression: an experimental study]. 189
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up 182
Adult attention-deficit/hyperactivity disorder in major depressed and bipolar subjects: role of personality traits and clinical implications 177
Low-dose topiramate in alcohol dependence: a single-blind, placebo-controlled study 174
Factors associated with the course of symptoms in bipolar disorder during a 1-year follow-up: depression vs. sub-threshold mixed state 172
Suicide by pencil 169
Alcohol protracted withdrawal syndrome: the role of anhedonia 169
Topiramate in Alcohol Use Disorders: Review and Update. 167
Anhedonia in Parkinson's disease patients with and without pathological gambling: A case-control study 162
Role of substance abuse comorbidity and personality on the outcome of depression in bipolar disorder: harm avoidance influences medium-term treatment outcome 161
Pregabalin in outpatient detoxification of subjects with mild-to-moderate alcohol withdrawal syndrome. 160
Behavioural addictions in adolescents and young adults: results from a prevalence study. 159
Pregabalin augmentation in treatment-resistant obsessive-compulsive disorder: a 16-week case series 157
PRELIMINARY ANALYSIS OF GENES INVOLVED IN INFLAMMATORY, OXIDATIVE PROCESSES AND CA2+SIGNALING IN BIPOLAR DISORDER AND COMORBIDITY FOR SUBSTANCE USE DISORDER 155
Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up 154
Gender Differences and Psychopathological Features Associated With Addictive Behaviors in Adolescents. 154
Acetyl-L-carnitine for alcohol craving and relapse prevention in anhedonic alcoholics: a randomized, double-blind, placebo-controlled pilot trial. 150
Il trattamento della schizofrenia 150
Serotoninergic and dopaminergic genes in bipolar disorder and response to treatments in bipolar depression. Investigation on a well-characterized naturalistic sample 147
Allostasis as a conceptual framework linking bipolar disorder and addiction 147
Oxcarbazepine in bipolar disorder: a critical review of the literature 146
Further evidence supporting the influence of brain-derived neurotrophic factor on the outcome of bipolar depression: independent effect of brain-derived neurotrophic factor and harm avoidance 144
Agomelatine increases BDNF serum levels in depressed patients in correlation with the improvement of depressive symptoms 144
Acetyl-l-Carnitine in the treatment of anhedonia, melancholic and negative symptoms in alcohol dependent subjects 143
Targeting the glutamatergic system to treat pathological gambling: current evidence and future perspectives 143
Gabapentin as add-on treatment for somatoform disorder: a case report 139
Behavioural addictions in adolescents and young adults: results from a prevalence study 139
Acetyl-L-Carnitine in the management of pain during methadone withdrawal syndrome 139
Aripiprazole, alcohol and substance abuse: a review 138
The assessment of post-detoxification anhedonia: influence of clinical and psychosocial variables 137
Neural correlates of cognitive control in gambling disorder: a systematic review of fMRI studies 134
Enhanced BDNF serum levels in patients with severe pathological gambling 133
Plasma levels of n-3 fatty acids in bipolar patients: Deficit restricted to DHA 132
Alcohol drinking patterns in young people: A survey-based study 132
Cocaine use disorders and serum magnesium profile 131
Dead under the bed: a case of Diogenes syndrome? 131
Amantadine in the treatment of pathological gambling: a case report 130
Aripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs. naltrexone 129
Dopaminergic and clinical correlates of high-frequency repetitive transcranial magnetic stimulation in gambling addiction: a SPECT case study. 129
Oxcarbazepine improves mood in patients with epilepsy. 128
Does DRD2 Taq1A Mediate Aripiprazole-Induced Gambling Disorder? A Pharmacogenetic Hypothesis 127
Transcranial electrical and magnetic stimulation (tES and TMS) for addiction medicine: A consensus paper on the present state of the science and the road ahead 127
Who`s the Leader, Mania or Depression? Predominant Polarity and Alcohol/Polysubstance Use in Bipolar Disorders 125
Reduced hedonic capacity in euthymic bipolar subjects: a trait-like feature? 124
Punding in non-demented Parkinson's disease patients: Relationship with psychiatric and addiction spectrum comorbidity 124
Oxcarbazepine improves mood in patients with epilepsy 123
Mono- and polysubstance dependent subjects differ on social factors, childhood trauma, personality, suicidal behaviour, and comorbid Axis I diagnoses 122
Enhanced BDNF serum levels in patients with severe pathological gambling 122
Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics 121
A possible new option for migraine management: agomelatine 121
Striatal presynaptic dopaminergic dysfunction in gambling disorder: A 123 I-FP-CIT SPECT study. 121
Who's the Leader, Mania or Depression? Predominant Polarity and Alcohol/Polysubstance Use in Bipolar Disorders 120
Chronic ketamine use increases serum levels of brain-derived neurotrophic factor. 119
The emerging role of melatonin agonists in the treatment of major depression: focus on agomelatine 118
Management of aripiprazole-induced tardive Pisa syndrome: A case report and literature review 116
Striatal presynaptic dopaminergic dysfunction in gambling disorder: A 123I-FP-CIT SPECT study 116
Relationship between craving and plasma leptin concentrations in patients with cocaine addiction. 116
Antidepressant treatment restores brain-derived neurotrophic factor serum levels and ameliorates motor function in Parkinson disease patients 115
Empathy ability is impaired in alcohol-dependent patients 111
Anhedonia in Parkinson's disease patients with and without pathological gambling: a case-control study 111
Prevalence and intensity of basic symptoms among cannabis users: an observational study 110
Temperament and character inventory dimensions and anhedonia in detoxified substance-dependent subjects 108
Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptoms 107
Anhedonia and substance dependence: clinical correlates and treatment options 106
Efficacy and safety of pregabalin in alcohol dependence 105
Agomelatine versus venlafaxine XR in the treatment of anhedonia in major depressive disorder: a pilot study 104
Harm avoidance moderates the influence of serotonin transporter gene variants on treatment outcome in bipolar patients 103
Nalmefene in Alcohol Use Disorder Subjects with Psychiatric Comorbidity: A Naturalistic Study. 103
Reduced fronto-temporal connectivity is associated with frontal gray matter density reduction and neuropsychological deficit in schizophrenia. 100
BDNF Val66Met polymorphism is associated with aggressive behavior in schizophrenia 100
Poprawa nastroju u chorych na padaczke leczonych okskarbazepina 100
Hopelessness, Dissociative Symptoms, and Suicide Risk in Major Depressive Disorder: Clinical and Biological Correlates 99
Paliperidone for treatment of obsessive compulsive resistant symptoms in schizophrenia: a case report. 99
Neuropsychological Performance in Alcohol Dependent Patients: A One-Year Longitudinal Study. 97
Dorsolateral Prefrontal Cortex Impairment in Methoxetamine-Induced Psychosis: An 18F-FDG PET/CT Case Study. 97
Substance-related psychopathology and aggressiveness in a nightlife holiday resort: Results from a pilot study in a psychiatric inpatient unit in Ibiza 95
Exploring peripheral biomarkers in psychostimulant use: A systematic review on neurotrophins, stress-related hormones, oxidative stress molecules and genetic factors 94
Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptoms. 90
null 90
Trends in alcohol-related deaths in the EU countries in 1980-2003 89
Pregabalin for alcohol dependence: a critical review of the literature 85
Major Depression in Comorbidity with Substance use Disorders: Patients' Features and Clinical-Neurobiological Rationale of Antidepressant Treatments 84
‘Suicide on Italian Instagram: Insights and implications for prevention and support’ 83
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression 72
Totale 18.500
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.272
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.272
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021277 0 0 0 0 0 0 0 0 0 101 144 32
2021/20221.030 80 91 33 53 59 44 52 176 64 69 132 177
2022/20232.918 279 309 204 366 210 278 191 302 357 100 170 152
2023/20241.910 143 358 103 141 125 246 84 105 78 115 192 220
2024/20252.917 172 145 218 171 268 129 138 188 430 222 428 408
2025/20265.674 732 214 286 548 1.013 381 1.062 459 428 551 0 0
Totale 19.360